Augmentation, Not Replacement: Debunking Common AI Myths Life Sciences - with Emmanuel Walckenaer of YSEOP
The AI in Business Podcast
00:00
Eli Lilly's Efficiency Gains in Pharma
I don't know enough about the inner workings of Eli Lilly to have any comments here. If a company in pharma is creating these reports more quickly, there is enough pipeline of those reports where they're definitely going to be able to stay busy doing reports because there's a backlog, there's priorities. And actually this guy, the ask is different. If you're going to help us to actually insource this work so that the guy who is actually working on the research, on the, you know, clinical trial, it could actually produce that with the help of a machine,. This would really allow the back-end force with a party or what we have to explain where, you know
Transcript
Play full episode
